Abiopharma

🔍 Wupen Yuen (Executive)

Company: Lumentum Holdings Inc. (LITE)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 3,860 shares of Common Stock at $827.6 per share (Direct)
  Date: 2026-08-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 101,934.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,500 shares of Common Stock at $827.82 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 100,434.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 6,705 shares of Common Stock at $866.71 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 93,729.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 500 shares of Common Stock at $898.15 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 93,229.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units.
• F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026.